Bio-Techne Corporation (NASDAQ:TECH) is highlighted as a profitable biotech stock with a new Buy rating and $65 price target from TD Cowen analyst Daniel Brennan. The analyst cites potential for margin expansion, strong organic growth, and undervalued valuation, while noting the company's focus on consumables and global life sciences operations.

Michelle Xia, CEO and co-founder of Chinese biotech firm Akeso, has become a billionaire after her company's cancer drug outperformed Merck's Keytruda in clinical trials. Akeso's drug, ivonescimab, gained global attention, leading to a 16% stock surge and a licensing deal with Summit Therapeutics for $500 million. Xia, a former U.S. researcher, founded Akeso in 2012 and has driven innovation in biotech, aiming to expand into neurodegenerative and autoimmune disease treatments.

The article highlights seven biotech stocks to watch as of July 10, 2025, including Thermo Fisher Scientific, AbbVie, ProKidney, Bloom Energy, Danaher, Moderna, and Vertex Pharmaceuticals. These companies are analyzed for their financial performance, market capitalization, stock price movements, and clinical trial progress in the biotech sector.

The article highlights seven biotech stocks to watch as of July 8th, 2025, including ProKidney, Thermo Fisher Scientific, Moderna, AbbVie, Danaher, Recursion Pharmaceuticals, and Vertex Pharmaceuticals. These companies are noted for their high trading volumes and financial metrics, with details on their products, market caps, stock performance, and industry relevance.

The article highlights three biotech stocks—AbbVie (ABBV), Thermo Fisher Scientific (TMO), and Vertex Pharmaceuticals (VRTX)—as top picks for investors. These companies are noted for their significant trading volume, diverse product portfolios in life sciences and biomedicine, and financial metrics reflecting their market positions. The text provides detailed financial data, including stock prices, market caps, and ratios, while emphasizing the high-risk, high-growth nature of biotech investments.